12:00 AM
 | 
Sep 17, 2012
 |  BC Week In Review  |  Company News  |  Other News

Mylan, Pfizer genitourinary news

Pfizer and Mylan settled a June 2010 patent suit filed in the U.S. District Court for the District of New Jersey claiming that Mylan's ANDA for a generic version of Pfizer's overactive bladder (OAB) drug ...

Read the full 159 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >